Home › Inspirations
Inspirational News
— Steal a chance to stay informed
A growing number of reports are asking how new cancer treatments reach patients, and where. We have gathered recent news, scientific articles and cost studies in one place so you can read the original sources for yourself.
Please note:These links open third-party websites, and some may require a subscription. Listing a report does not mean Springleaf endorses its content or any treatment, provider or destination. Scientific articles are research and reviews, not treatment recommendations, and many describe early-stage studies whose results may not apply to every patient. Please discuss any option with your oncologist.
Recent regulatory news 5 reports, newest first
Coverage of the approval in China of a CAR-T cell therapy for solid tumours.
When the world's first solid-tumour CAR-T gets approved in China
Read the report (opens in a new tab)CAR T cell therapy for solid cancer scores first approval in China
Read the report (opens in a new tab)China Approves World's First CAR T-Cell Therapy for Solid Tumors
Read the report (opens in a new tab)CAR-T cell therapy for tumors approved
Read the report (opens in a new tab)Solid Tumor CAR-T Therapy Approved in China, a World First
Read the report (opens in a new tab)Foreign patients seeking treatment in China 12 reports, newest first
Coverage of patients travelling to China for cancer care, and of China’s fast-growing role in cancer medicine.
From the "World Factory" to the "World Hospital", are hordes of foreigners coming to China to receive anti-cancer treatment?
Read the report (opens in a new tab)China becoming CAR-T destination for US patients: WSJ
Read the report (opens in a new tab)Patients Are Flying to China for the Latest Cancer Treatment
Read the report (opens in a new tab)From spinal implant to cancer therapy, foreign patients seek out China's medical advances
Read the report (opens in a new tab)Big Pharma Is Hooked on Chinese Licensing Deals
Read the report (opens in a new tab)Cancer Drug Approvals in China Outpace Those in US, Study Finds
Read the report (opens in a new tab)How trips to Asia are making some Americans healthy again
Read the report (opens in a new tab)Why cancer patients are travelling to China
Read the report (opens in a new tab)Why hospitals in China, including Raffles Medical, are attracting more foreign patients
Read the report (opens in a new tab)China's nascent medical tourism lures foreign patients with cutting-edge, cheap medical care
Read the report (opens in a new tab)China Emerges as a Global Hub for Affordable CAR-T Therapy, Drawing Foreign Patients with Advanced Cancer Care
Read the report (opens in a new tab)China Lures Foreign Patients With Cutting-Edge, Cheap Medical Care
Read the report (opens in a new tab)Scientific articles on CAR-T therapy 22 articles
Reviews and studies from scientific journals, plus institute news, on CAR-T therapy for solid tumours. Many describe early-phase research. Results may not apply to every patient, and these articles are not treatment recommendations.
Overviews and reviews 8 articles, newest first
Broad reviews of where CAR-T therapy stands today, its challenges and where it is heading.
Bridging Gene Therapy and Immuno-Oncology: Emerging Platforms for Personalized Cancer Treatment – A Narrative Review
Read the article (opens in a new tab)CAR T cell therapy beyond cancer: current status, challenges and future prospects
Read the article (opens in a new tab)A guide to CAR T cell therapies: development, current status and future prospects
Read the article (opens in a new tab)Application of CAR-T therapy in solid tumors: current opportunities and challenges
Read the article (opens in a new tab)CAR-T cells in solid tumors: Challenges and breakthroughs
Read the article (opens in a new tab)Optimizing CAR T cell therapy for solid tumours: a clinical perspective
Read the article (opens in a new tab)CAR-T therapy in solid tumors
Read the article (opens in a new tab)Beyond the blood: expanding CAR T cell therapy to solid tumors
Read the article (opens in a new tab)Clinical trial evidence 5 articles, newest first
What early-phase and later clinical trials, and pooled analyses of them, show so far.
The safety and efficacy of chimeric antigen receptor-T cell therapy in solid malignancies: a systematic review and meta-analysis
Read the article (opens in a new tab)Clinical evidence on non-viral CAR-T cell therapies for solid tumors: a scoping review
Read the article (opens in a new tab)CAR T Cell Therapy in Solid Tumors: Lessons From Early-Phase Clinical Trials and Biological Barriers to Efficacy
Read the article (opens in a new tab)Emerging advances in CAR-T therapy for solid tumors: latest clinical trial updates from 2025 ASCO annual meeting
Read the article (opens in a new tab)Challenges and breakthroughs: current landscape and future prospects of CAR-T cell therapy clinical trials for solid tumors
Read the article (opens in a new tab)Next-generation CAR-T engineering 6 articles, newest first
New designs and methods that aim to make CAR-T cells stronger, safer or easier to produce.
NKG2D overexpression potentiates CAR-T cells through costimulation by tumor NKG2D ligands
Read the article (opens in a new tab)CRISPRa screen unveils noncanonical NF-κB to boost the antitumor activity of TCR-based CAR-T cells
Read the article (opens in a new tab)Harnessing nature to engineer stronger CAR-T cells
Read the article (opens in a new tab)Next generation CAR-T cells to tackle solid tumors
Read the article (opens in a new tab)In vivo CAR T cell generation to treat cancer and autoimmune disease
Read the article (opens in a new tab)From molecular design to clinical translation: dual-targeted CAR-T strategies in cancer immunotherapy
Read the article (opens in a new tab)Studies in specific cancers 3 articles, newest first
Research focused on ovarian, gastric and triple-negative breast cancer.
CAR-T Cell Therapy in Solid Tumors: Implications of Satri-cel for Gastric and Gastrointestinal Cancers
Read the article (opens in a new tab)Dual-Target CAR-T Cells in Triple-Negative Breast Cancer: Recent Advances and Translational Challenges
Read the article (opens in a new tab)T-cell receptor–like chimeric antigen receptor T cells targeting mesothelin: A first-in-human dose-escalation trial for platinum-resistant advanced ovarian cancer
Read the article (opens in a new tab)Cost comparisons of cancer treatment 5 items, newest first
Studies and reports on the cost, cost-effectiveness and out-of-pocket burden of cancer treatment, including comparisons between China and the United States.
US cancer patients need lifesaving drugs. Some have to get them in China.
Read the article (opens in a new tab)Tumor treating field plus chemotherapy for locally advanced pancreatic adenocarcinoma: An international cost-effectiveness analysis
Read the study (opens in a new tab)Cost-effectiveness of benmelstobart-anlotinib-chemotherapy in extensive-stage small-cell lung cancer: A comparative analysis across United States and Chinese healthcare systems
Read the study (opens in a new tab)Financial toxicity for cancer patients: Out-of-pocket costs by cancer diagnosis in traditional Medicare
Read the study (opens in a new tab)Cost-utility analysis of olaparib assisted targeted therapy for BRCA mutation HER2-negative early breast cancer in China and in the United States
Read the study (opens in a new tab)Watch & listen 6 videos and podcasts
Video and audio reports on why patients are travelling for cancer treatment.
Why cancer patients are flying to China for treatment - Asia Specific podcast, BBC World Service
Watch or listen (opens in a new tab)為何許多癌症患者飛赴中國接受治療－ BBC News 中文
Watch or listen (opens in a new tab)Medical tourism is booming, & China wants in | Meanwhile in Asia
Watch or listen (opens in a new tab)Cancer Patients Are Fleeing to CHINA for Treatment!
Watch or listen (opens in a new tab)Why More People Are Choosing China For Cancer Treatment
Watch or listen (opens in a new tab)Why a Cancer Patient Traveled Across the World to China for Treatment
Watch or listen (opens in a new tab)Steal a chance by talking to us
Share with us your thoughts, your questions, or simply where you are today. Tell us how we can support your journey, and we will get back to you.